

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 6.75681693 |
| 2 | drug catabolic process (GO:0042737) | 6.07210255 |
| 3 | axon ensheathment in central nervous system (GO:0032291) | 5.62070157 |
| 4 | central nervous system myelination (GO:0022010) | 5.62070157 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 5.02808624 |
| 6 | tryptophan catabolic process (GO:0006569) | 4.92841003 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 4.92841003 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 4.92841003 |
| 9 | epoxygenase P450 pathway (GO:0019373) | 4.74891838 |
| 10 | behavioral response to nicotine (GO:0035095) | 4.57734577 |
| 11 | cellular ketone body metabolic process (GO:0046950) | 4.56055550 |
| 12 | gamma-aminobutyric acid transport (GO:0015812) | 4.44757257 |
| 13 | tryptophan metabolic process (GO:0006568) | 4.37919386 |
| 14 | oxidative demethylation (GO:0070989) | 4.37162372 |
| 15 | neuron cell-cell adhesion (GO:0007158) | 4.36551495 |
| 16 | presynaptic membrane assembly (GO:0097105) | 4.36491340 |
| 17 | kynurenine metabolic process (GO:0070189) | 4.31773943 |
| 18 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.27036070 |
| 19 | aromatic amino acid family catabolic process (GO:0009074) | 4.17399469 |
| 20 | glyoxylate metabolic process (GO:0046487) | 4.13601678 |
| 21 | presynaptic membrane organization (GO:0097090) | 4.10652318 |
| 22 | ketone body metabolic process (GO:1902224) | 4.06565355 |
| 23 | S-adenosylmethionine metabolic process (GO:0046500) | 3.96742939 |
| 24 | indolalkylamine metabolic process (GO:0006586) | 3.96307967 |
| 25 | response to pheromone (GO:0019236) | 3.89345251 |
| 26 | L-amino acid import (GO:0043092) | 3.87370751 |
| 27 | fucose catabolic process (GO:0019317) | 3.86919933 |
| 28 | L-fucose metabolic process (GO:0042354) | 3.86919933 |
| 29 | L-fucose catabolic process (GO:0042355) | 3.86919933 |
| 30 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.76074592 |
| 31 | fatty acid elongation (GO:0030497) | 3.73511535 |
| 32 | nucleobase catabolic process (GO:0046113) | 3.72533092 |
| 33 | complement activation, alternative pathway (GO:0006957) | 3.64204029 |
| 34 | drug metabolic process (GO:0017144) | 3.61367081 |
| 35 | amino acid import (GO:0043090) | 3.57452242 |
| 36 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.57234436 |
| 37 | vocalization behavior (GO:0071625) | 3.52611048 |
| 38 | neuronal action potential propagation (GO:0019227) | 3.51151701 |
| 39 | negative regulation of neurotransmitter transport (GO:0051589) | 3.40337603 |
| 40 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.37753512 |
| 41 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.33249906 |
| 42 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.32527742 |
| 43 | L-phenylalanine catabolic process (GO:0006559) | 3.32527742 |
| 44 | amine catabolic process (GO:0009310) | 3.29925556 |
| 45 | cellular biogenic amine catabolic process (GO:0042402) | 3.29925556 |
| 46 | indole-containing compound metabolic process (GO:0042430) | 3.26745918 |
| 47 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.25971446 |
| 48 | amino acid salvage (GO:0043102) | 3.25333463 |
| 49 | L-methionine salvage (GO:0071267) | 3.25333463 |
| 50 | L-methionine biosynthetic process (GO:0071265) | 3.25333463 |
| 51 | bile acid biosynthetic process (GO:0006699) | 3.23922172 |
| 52 | serine family amino acid catabolic process (GO:0009071) | 3.23586864 |
| 53 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.20624653 |
| 54 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.20092648 |
| 55 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.16777642 |
| 56 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.13058173 |
| 57 | arginine metabolic process (GO:0006525) | 3.11331901 |
| 58 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.10815401 |
| 59 | neuronal action potential (GO:0019228) | 3.10810423 |
| 60 | cellular glucuronidation (GO:0052695) | 3.09425303 |
| 61 | regulation of protein activation cascade (GO:2000257) | 3.07483916 |
| 62 | aromatic amino acid family metabolic process (GO:0009072) | 3.06645083 |
| 63 | succinate metabolic process (GO:0006105) | 3.06526832 |
| 64 | uronic acid metabolic process (GO:0006063) | 3.05046842 |
| 65 | glucuronate metabolic process (GO:0019585) | 3.05046842 |
| 66 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.05041425 |
| 67 | * negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.03626368 |
| 68 | neurotransmitter uptake (GO:0001504) | 3.02945781 |
| 69 | benzene-containing compound metabolic process (GO:0042537) | 3.02919526 |
| 70 | myelination (GO:0042552) | 3.01380892 |
| 71 | regulation of triglyceride catabolic process (GO:0010896) | 2.99122061 |
| 72 | negative regulation of protein localization to cell surface (GO:2000009) | 2.98406036 |
| 73 | transmission of nerve impulse (GO:0019226) | 2.98068726 |
| 74 | protein-cofactor linkage (GO:0018065) | 2.96459508 |
| 75 | ensheathment of neurons (GO:0007272) | 2.95683581 |
| 76 | axon ensheathment (GO:0008366) | 2.95683581 |
| 77 | glutamate receptor signaling pathway (GO:0007215) | 2.92962616 |
| 78 | coenzyme catabolic process (GO:0009109) | 2.92864986 |
| 79 | arginine catabolic process (GO:0006527) | 2.92188514 |
| 80 | dicarboxylic acid catabolic process (GO:0043649) | 2.91599353 |
| 81 | regulation of complement activation (GO:0030449) | 2.90910303 |
| 82 | startle response (GO:0001964) | 2.90797746 |
| 83 | neuron recognition (GO:0008038) | 2.89633786 |
| 84 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.88467149 |
| 85 | respiratory electron transport chain (GO:0022904) | 2.86315008 |
| 86 | postsynaptic membrane organization (GO:0001941) | 2.85526811 |
| 87 | alanine transport (GO:0032328) | 2.84547147 |
| 88 | import into cell (GO:0098657) | 2.83903395 |
| 89 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.82672010 |
| 90 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.81304016 |
| 91 | detection of light stimulus involved in visual perception (GO:0050908) | 2.81304016 |
| 92 | ethanol oxidation (GO:0006069) | 2.76778025 |
| 93 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.76758461 |
| 94 | alpha-amino acid catabolic process (GO:1901606) | 2.76545649 |
| 95 | electron transport chain (GO:0022900) | 2.76224529 |
| 96 | neuron-neuron synaptic transmission (GO:0007270) | 2.76090275 |
| 97 | response to epinephrine (GO:0071871) | 2.75552706 |
| 98 | positive regulation of synapse assembly (GO:0051965) | 2.75522415 |
| 99 | protein polyglutamylation (GO:0018095) | 2.74612834 |
| 100 | glycerophospholipid catabolic process (GO:0046475) | 2.74356462 |
| 101 | phenylpropanoid metabolic process (GO:0009698) | 2.73007373 |
| 102 | positive regulation of fatty acid transport (GO:2000193) | 2.72481327 |
| 103 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.71755411 |
| 104 | protein localization to synapse (GO:0035418) | 2.70681462 |
| 105 | bile acid metabolic process (GO:0008206) | 2.68020792 |
| 106 | cysteine metabolic process (GO:0006534) | 2.67446581 |
| 107 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.66056627 |
| 108 | epithelial cilium movement (GO:0003351) | 2.65247509 |
| 109 | glycine transport (GO:0015816) | 2.64837290 |
| 110 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.63115331 |
| 111 | dopamine transport (GO:0015872) | 2.63056193 |
| 112 | methionine biosynthetic process (GO:0009086) | 2.62411568 |
| 113 | bile acid and bile salt transport (GO:0015721) | 2.59512377 |
| 114 | oligodendrocyte differentiation (GO:0048709) | 2.58696562 |
| 115 | * positive regulation of action potential (GO:0045760) | 2.57457751 |
| 116 | platelet dense granule organization (GO:0060155) | 2.56306526 |
| 117 | flavonoid metabolic process (GO:0009812) | 2.56302146 |
| 118 | alkaloid metabolic process (GO:0009820) | 2.56302006 |
| 119 | cellular response to epinephrine stimulus (GO:0071872) | 2.55545117 |
| 120 | regulation of glucokinase activity (GO:0033131) | 2.55459627 |
| 121 | regulation of hexokinase activity (GO:1903299) | 2.55459627 |
| 122 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.55191918 |
| 123 | DNA deamination (GO:0045006) | 2.54494584 |
| 124 | cAMP catabolic process (GO:0006198) | 2.54241223 |
| 125 | positive regulation of amino acid transport (GO:0051957) | 2.53694613 |
| 126 | adult walking behavior (GO:0007628) | 2.52679726 |
| 127 | amino-acid betaine metabolic process (GO:0006577) | 2.52526046 |
| 128 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.52432997 |
| 129 | primary amino compound metabolic process (GO:1901160) | 2.50969087 |
| 130 | opsonization (GO:0008228) | 2.50040131 |
| 131 | synaptic transmission, glutamatergic (GO:0035249) | 2.49987959 |
| 132 | neuron remodeling (GO:0016322) | 2.49925076 |
| 133 | axoneme assembly (GO:0035082) | 2.49751515 |
| 134 | acidic amino acid transport (GO:0015800) | 2.49254165 |
| 135 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.49129809 |
| 136 | L-phenylalanine metabolic process (GO:0006558) | 2.49129809 |
| 137 | sulfation (GO:0051923) | 2.49116224 |
| 138 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.49037859 |
| 139 | limb bud formation (GO:0060174) | 2.48999291 |
| 140 | C4-dicarboxylate transport (GO:0015740) | 2.48524346 |
| 141 | ATP synthesis coupled proton transport (GO:0015986) | 2.46674255 |
| 142 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.46674255 |
| 143 | imidazole-containing compound metabolic process (GO:0052803) | 2.46094731 |
| 144 | cellular amino acid catabolic process (GO:0009063) | 2.45454545 |
| 145 | synaptic vesicle exocytosis (GO:0016079) | 2.44713100 |
| 146 | tyrosine metabolic process (GO:0006570) | 2.40968343 |
| 147 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.39164551 |
| 148 | xenobiotic catabolic process (GO:0042178) | 2.38856247 |
| 149 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.38268985 |
| 150 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.36681595 |
| 151 | organic cation transport (GO:0015695) | 2.35447096 |
| 152 | piRNA metabolic process (GO:0034587) | 2.34969479 |
| 153 | kidney morphogenesis (GO:0060993) | 2.34649750 |
| 154 | nonmotile primary cilium assembly (GO:0035058) | 2.33932096 |
| 155 | membrane assembly (GO:0071709) | 2.33812909 |
| 156 | * negative regulation of synaptic transmission (GO:0050805) | 2.33466085 |
| 157 | positive regulation of organic acid transport (GO:0032892) | 2.33339385 |
| 158 | neurotransmitter metabolic process (GO:0042133) | 2.32959003 |
| 159 | neurotransmitter secretion (GO:0007269) | 2.32664656 |
| 160 | short-term memory (GO:0007614) | 2.31863670 |
| 161 | aldehyde catabolic process (GO:0046185) | 2.31732763 |
| 162 | cilium morphogenesis (GO:0060271) | 2.31648967 |
| 163 | regulation of fibrinolysis (GO:0051917) | 2.31354943 |
| 164 | peptidyl-glutamic acid modification (GO:0018200) | 2.31126197 |
| 165 | regulation of sequestering of triglyceride (GO:0010889) | 2.30089755 |
| 166 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.29294116 |
| 167 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.28877460 |
| 168 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.28877460 |
| 169 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.27544848 |
| 170 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.26943983 |
| 171 | regulation of collateral sprouting (GO:0048670) | 2.26687701 |
| 172 | neurotransmitter transport (GO:0006836) | 2.26624847 |
| 173 | retina layer formation (GO:0010842) | 2.26021069 |
| 174 | regulation of synapse assembly (GO:0051963) | 2.24458647 |
| 175 | cerebellar granule cell differentiation (GO:0021707) | 2.24260177 |
| 176 | synapse assembly (GO:0007416) | 2.24200833 |
| 177 | detection of calcium ion (GO:0005513) | 2.23841689 |
| 178 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.23732628 |
| 179 | response to cocaine (GO:0042220) | 2.23582835 |
| 180 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.22070923 |
| 181 | response to auditory stimulus (GO:0010996) | 2.21821513 |
| 182 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.21723141 |
| 183 | * regulation of synaptic transmission, GABAergic (GO:0032228) | 2.21078379 |
| 184 | eye photoreceptor cell differentiation (GO:0001754) | 2.21076840 |
| 185 | photoreceptor cell differentiation (GO:0046530) | 2.21076840 |
| 186 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.21051318 |
| 187 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.20544657 |
| 188 | response to methylmercury (GO:0051597) | 2.18478707 |
| 189 | aggressive behavior (GO:0002118) | 2.18362243 |
| 190 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.18219457 |
| 191 | response to histamine (GO:0034776) | 2.17665470 |
| 192 | regulation of respiratory system process (GO:0044065) | 2.17097919 |
| 193 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.16247336 |
| 194 | axonal fasciculation (GO:0007413) | 2.15527432 |
| 195 | potassium ion import (GO:0010107) | 2.15315934 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.09918574 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.95106525 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.59703021 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.65599209 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.62713139 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.58737740 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.54759832 |
| 8 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.31462960 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.28282872 |
| 10 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.27411395 |
| 11 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.23855236 |
| 12 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.22814541 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.22584863 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.22012528 |
| 15 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.16469304 |
| 16 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.16469304 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.11478605 |
| 18 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.04819198 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.04284940 |
| 20 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.99104798 |
| 21 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.91861312 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.87197936 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.85655030 |
| 24 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.85354386 |
| 25 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.84985853 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.84811725 |
| 27 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.83921164 |
| 28 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.82838729 |
| 29 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.80218986 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.78695100 |
| 31 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.78181008 |
| 32 | P300_19829295_ChIP-Seq_ESCs_Human | 1.77560242 |
| 33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75146252 |
| 34 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.72701673 |
| 35 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.70666505 |
| 36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.69055382 |
| 37 | VDR_22108803_ChIP-Seq_LS180_Human | 1.64977759 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.63807953 |
| 39 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.62936011 |
| 40 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.60409734 |
| 41 | EWS_26573619_Chip-Seq_HEK293_Human | 1.59992637 |
| 42 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59862546 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.59836486 |
| 44 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.56240456 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.55706687 |
| 46 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.54788715 |
| 47 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.54625077 |
| 48 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.54050804 |
| 49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.52067999 |
| 50 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.48827777 |
| 51 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.47799619 |
| 52 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.47558903 |
| 53 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.44382612 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.43957363 |
| 55 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.43013443 |
| 56 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.42814285 |
| 57 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.42814285 |
| 58 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.42367040 |
| 59 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.41358398 |
| 60 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.40683542 |
| 61 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.40442599 |
| 62 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.40351572 |
| 63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.39461104 |
| 64 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.35754335 |
| 65 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.35151869 |
| 66 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.34252534 |
| 67 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.32038601 |
| 68 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.32038601 |
| 69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.30344122 |
| 70 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.29370374 |
| 71 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.28302490 |
| 72 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.27222747 |
| 73 | AR_25329375_ChIP-Seq_VCAP_Human | 1.26264392 |
| 74 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24286099 |
| 75 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23637948 |
| 76 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23484989 |
| 77 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.22769467 |
| 78 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.22769467 |
| 79 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21524416 |
| 80 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.21503759 |
| 81 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.21427934 |
| 82 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.18841398 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.17967972 |
| 84 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17353926 |
| 85 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.16114682 |
| 86 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.15618267 |
| 87 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.15162317 |
| 88 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14730647 |
| 89 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14407303 |
| 90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14291735 |
| 91 | TCF4_23295773_ChIP-Seq_U87_Human | 1.13684836 |
| 92 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.13348787 |
| 93 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12823240 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12407657 |
| 95 | NCOR_22424771_ChIP-Seq_293T_Human | 1.12354624 |
| 96 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.12048208 |
| 97 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.11460705 |
| 98 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11391242 |
| 99 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11366319 |
| 100 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11206748 |
| 101 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.11112970 |
| 102 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10891175 |
| 103 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.09142567 |
| 104 | AR_20517297_ChIP-Seq_VCAP_Human | 1.08885763 |
| 105 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08848742 |
| 106 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.05931442 |
| 107 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05335232 |
| 108 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.04738214 |
| 109 | KDM2B_26808549_Chip-Seq_REH_Human | 1.04674529 |
| 110 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04415095 |
| 111 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04415095 |
| 112 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.04410182 |
| 113 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04354135 |
| 114 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.04328792 |
| 115 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03729785 |
| 116 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.03690346 |
| 117 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03610449 |
| 118 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.03417805 |
| 119 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02584311 |
| 120 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.02017110 |
| 121 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.01673431 |
| 122 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01575677 |
| 123 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01498617 |
| 124 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.01380536 |
| 125 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00994319 |
| 126 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00263645 |
| 127 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00263645 |
| 128 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.99840500 |
| 129 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.99797177 |
| 130 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.99527930 |
| 131 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.99347911 |
| 132 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.99328251 |
| 133 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99203463 |
| 134 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.98887279 |
| 135 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98723831 |
| 136 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98685851 |
| 137 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98602063 |
| 138 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.98333430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 3.83738889 |
| 2 | MP0008875_abnormal_xenobiotic_pharmacok | 3.75583541 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.52008588 |
| 4 | MP0009046_muscle_twitch | 3.04396992 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 2.94279435 |
| 6 | MP0002064_seizures | 2.68606493 |
| 7 | MP0001486_abnormal_startle_reflex | 2.66582313 |
| 8 | MP0009745_abnormal_behavioral_response | 2.61925311 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 2.52106717 |
| 10 | MP0002272_abnormal_nervous_system | 2.51027065 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.50248701 |
| 12 | MP0005365_abnormal_bile_salt | 2.41879246 |
| 13 | MP0003136_yellow_coat_color | 2.36995536 |
| 14 | MP0003252_abnormal_bile_duct | 2.35495890 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.34446756 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.27720369 |
| 17 | MP0003690_abnormal_glial_cell | 2.24841643 |
| 18 | MP0003646_muscle_fatigue | 2.22705754 |
| 19 | MP0000920_abnormal_myelination | 2.20834563 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.15763286 |
| 21 | MP0004270_analgesia | 2.14182468 |
| 22 | MP0002572_abnormal_emotion/affect_behav | 2.12776942 |
| 23 | MP0001529_abnormal_vocalization | 2.07677342 |
| 24 | MP0001501_abnormal_sleep_pattern | 2.06898833 |
| 25 | MP0001968_abnormal_touch/_nociception | 2.05383753 |
| 26 | MP0001440_abnormal_grooming_behavior | 2.04371392 |
| 27 | MP0003011_delayed_dark_adaptation | 2.00111762 |
| 28 | MP0008877_abnormal_DNA_methylation | 1.98472479 |
| 29 | MP0005646_abnormal_pituitary_gland | 1.96358664 |
| 30 | MP0002063_abnormal_learning/memory/cond | 1.95221389 |
| 31 | MP0005171_absent_coat_pigmentation | 1.94069367 |
| 32 | MP0002736_abnormal_nociception_after | 1.89744654 |
| 33 | MP0002735_abnormal_chemical_nociception | 1.83462218 |
| 34 | MP0006072_abnormal_retinal_apoptosis | 1.80280345 |
| 35 | MP0004742_abnormal_vestibular_system | 1.79482334 |
| 36 | MP0004142_abnormal_muscle_tone | 1.76955255 |
| 37 | MP0002734_abnormal_mechanical_nocicepti | 1.76060202 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.74857572 |
| 39 | MP0010329_abnormal_lipoprotein_level | 1.72057004 |
| 40 | MP0008872_abnormal_physiological_respon | 1.71841036 |
| 41 | MP0001188_hyperpigmentation | 1.69065211 |
| 42 | MP0004133_heterotaxia | 1.67908664 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 1.64343429 |
| 44 | MP0005360_urolithiasis | 1.62233587 |
| 45 | MP0005409_darkened_coat_color | 1.61368563 |
| 46 | MP0005253_abnormal_eye_physiology | 1.61236777 |
| 47 | MP0006292_abnormal_olfactory_placode | 1.60246979 |
| 48 | MP0006276_abnormal_autonomic_nervous | 1.57897952 |
| 49 | MP0000778_abnormal_nervous_system | 1.57209776 |
| 50 | MP0003329_amyloid_beta_deposits | 1.53748802 |
| 51 | MP0000566_synostosis | 1.53259741 |
| 52 | MP0003787_abnormal_imprinting | 1.52387816 |
| 53 | MP0004043_abnormal_pH_regulation | 1.48947438 |
| 54 | MP0005670_abnormal_white_adipose | 1.48836078 |
| 55 | MP0005386_behavior/neurological_phenoty | 1.41293177 |
| 56 | MP0004924_abnormal_behavior | 1.41293177 |
| 57 | MP0005551_abnormal_eye_electrophysiolog | 1.37797687 |
| 58 | MP0001905_abnormal_dopamine_level | 1.35745487 |
| 59 | MP0001986_abnormal_taste_sensitivity | 1.34522423 |
| 60 | MP0003950_abnormal_plasma_membrane | 1.33094450 |
| 61 | MP0001970_abnormal_pain_threshold | 1.33086387 |
| 62 | MP0009780_abnormal_chondrocyte_physiolo | 1.32688022 |
| 63 | MP0003283_abnormal_digestive_organ | 1.29880169 |
| 64 | MP0003634_abnormal_glial_cell | 1.29054218 |
| 65 | MP0004130_abnormal_muscle_cell | 1.28381648 |
| 66 | MP0000751_myopathy | 1.27738054 |
| 67 | MP0002653_abnormal_ependyma_morphology | 1.27648660 |
| 68 | MP0001984_abnormal_olfaction | 1.27125035 |
| 69 | MP0004885_abnormal_endolymph | 1.26974110 |
| 70 | MP0002733_abnormal_thermal_nociception | 1.26475805 |
| 71 | MP0002557_abnormal_social/conspecific_i | 1.23418439 |
| 72 | MP0008569_lethality_at_weaning | 1.19290673 |
| 73 | MP0005084_abnormal_gallbladder_morpholo | 1.19181993 |
| 74 | MP0001963_abnormal_hearing_physiology | 1.18793386 |
| 75 | MP0002234_abnormal_pharynx_morphology | 1.18679617 |
| 76 | * MP0004215_abnormal_myocardial_fiber | 1.18372093 |
| 77 | MP0002229_neurodegeneration | 1.17554649 |
| 78 | MP0001485_abnormal_pinna_reflex | 1.15683291 |
| 79 | MP0005535_abnormal_body_temperature | 1.15258354 |
| 80 | MP0003137_abnormal_impulse_conducting | 1.15182708 |
| 81 | MP0005377_hearing/vestibular/ear_phenot | 1.15120297 |
| 82 | MP0003878_abnormal_ear_physiology | 1.15120297 |
| 83 | MP0003195_calcinosis | 1.14629647 |
| 84 | MP0000427_abnormal_hair_cycle | 1.13957213 |
| 85 | MP0002876_abnormal_thyroid_physiology | 1.13525290 |
| 86 | MP0002066_abnormal_motor_capabilities/c | 1.13272360 |
| 87 | MP0002882_abnormal_neuron_morphology | 1.08670407 |
| 88 | MP0002184_abnormal_innervation | 1.08076042 |
| 89 | MP0000569_abnormal_digit_pigmentation | 1.07942001 |
| 90 | MP0004381_abnormal_hair_follicle | 1.07629398 |
| 91 | MP0001764_abnormal_homeostasis | 1.05814992 |
| 92 | MP0003633_abnormal_nervous_system | 1.04684851 |
| 93 | MP0005410_abnormal_fertilization | 1.02588530 |
| 94 | MP0000631_abnormal_neuroendocrine_gland | 1.02559340 |
| 95 | MP0004145_abnormal_muscle_electrophysio | 1.01594985 |
| 96 | MP0000026_abnormal_inner_ear | 1.00324443 |
| 97 | MP0000372_irregular_coat_pigmentation | 0.98857924 |
| 98 | MP0003631_nervous_system_phenotype | 0.98050646 |
| 99 | MP0002928_abnormal_bile_duct | 0.96924587 |
| 100 | MP0004858_abnormal_nervous_system | 0.96786933 |
| 101 | MP0005187_abnormal_penis_morphology | 0.94987562 |
| 102 | MP0000955_abnormal_spinal_cord | 0.94217118 |
| 103 | MP0002909_abnormal_adrenal_gland | 0.93472015 |
| 104 | * MP0004484_altered_response_of | 0.93342783 |
| 105 | MP0004036_abnormal_muscle_relaxation | 0.93136048 |
| 106 | MP0000604_amyloidosis | 0.91283511 |
| 107 | MP0002822_catalepsy | 0.91025831 |
| 108 | MP0002752_abnormal_somatic_nervous | 0.90914658 |
| 109 | MP0005666_abnormal_adipose_tissue | 0.90498581 |
| 110 | MP0002282_abnormal_trachea_morphology | 0.89841319 |
| 111 | * MP0004085_abnormal_heartbeat | 0.88987395 |
| 112 | MP0002102_abnormal_ear_morphology | 0.88909295 |
| 113 | MP0003632_abnormal_nervous_system | 0.87939666 |
| 114 | MP0003938_abnormal_ear_development | 0.87613859 |
| 115 | MP0001502_abnormal_circadian_rhythm | 0.86512751 |
| 116 | MP0008260_abnormal_autophagy | 0.86186925 |
| 117 | MP0009764_decreased_sensitivity_to | 0.86146647 |
| 118 | MP0004147_increased_porphyrin_level | 0.86084967 |
| 119 | MP0005167_abnormal_blood-brain_barrier | 0.84278057 |
| 120 | MP0005448_abnormal_energy_balance | 0.83449721 |
| 121 | * MP0000230_abnormal_systemic_arterial | 0.80856121 |
| 122 | MP0001666_abnormal_nutrient_absorption | 0.78755109 |
| 123 | MP0005332_abnormal_amino_acid | 0.78675657 |
| 124 | * MP0002972_abnormal_cardiac_muscle | 0.78601839 |
| 125 | MP0010368_abnormal_lymphatic_system | 0.76306863 |
| 126 | MP0002971_abnormal_brown_adipose | 0.75727741 |
| 127 | MP0001177_atelectasis | 0.75355328 |
| 128 | MP0008874_decreased_physiological_sensi | 0.74187134 |
| 129 | * MP0005620_abnormal_muscle_contractility | 0.74066958 |
| 130 | MP0001661_extended_life_span | 0.74005500 |
| 131 | MP0005379_endocrine/exocrine_gland_phen | 0.73484347 |
| 132 | MP0004185_abnormal_adipocyte_glucose | 0.71769374 |
| 133 | MP0002751_abnormal_autonomic_nervous | 0.71689109 |
| 134 | MP0010386_abnormal_urinary_bladder | 0.71462850 |
| 135 | MP0005636_abnormal_mineral_homeostasis | 0.70631597 |
| 136 | MP0005195_abnormal_posterior_eye | 0.67641885 |
| 137 | MP0002152_abnormal_brain_morphology | 0.66808880 |
| 138 | MP0002090_abnormal_vision | 0.66512631 |
| 139 | MP0003879_abnormal_hair_cell | 0.64837290 |
| 140 | MP0002118_abnormal_lipid_homeostasis | 0.63580482 |
| 141 | MP0005330_cardiomyopathy | 0.63350357 |
| 142 | MP0002069_abnormal_eating/drinking_beha | 0.62486657 |
| 143 | MP0002638_abnormal_pupillary_reflex | 0.61400752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.73055631 |
| 2 | Hyperventilation (HP:0002883) | 4.54220095 |
| 3 | Pancreatic cysts (HP:0001737) | 4.37346064 |
| 4 | Pancreatic fibrosis (HP:0100732) | 3.89111255 |
| 5 | True hermaphroditism (HP:0010459) | 3.77744138 |
| 6 | Molar tooth sign on MRI (HP:0002419) | 3.76414743 |
| 7 | Abnormality of midbrain morphology (HP:0002418) | 3.76414743 |
| 8 | Atonic seizures (HP:0010819) | 3.74106402 |
| 9 | Acute necrotizing encephalopathy (HP:0006965) | 3.67756970 |
| 10 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.56402038 |
| 11 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.56402038 |
| 12 | Congenital stationary night blindness (HP:0007642) | 3.55013915 |
| 13 | Febrile seizures (HP:0002373) | 3.54551183 |
| 14 | Epileptic encephalopathy (HP:0200134) | 3.52788035 |
| 15 | Neurofibrillary tangles (HP:0002185) | 3.52661118 |
| 16 | Nephronophthisis (HP:0000090) | 3.40932242 |
| 17 | Complement deficiency (HP:0004431) | 3.36721293 |
| 18 | Progressive macrocephaly (HP:0004481) | 3.36185087 |
| 19 | Acute encephalopathy (HP:0006846) | 3.29580861 |
| 20 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.27757384 |
| 21 | Focal seizures (HP:0007359) | 3.21644882 |
| 22 | Prolonged partial thromboplastin time (HP:0003645) | 3.21512219 |
| 23 | Abnormality of the renal cortex (HP:0011035) | 3.16193267 |
| 24 | Conjugated hyperbilirubinemia (HP:0002908) | 3.13711233 |
| 25 | Chronic hepatic failure (HP:0100626) | 2.98366417 |
| 26 | Type II lissencephaly (HP:0007260) | 2.93894754 |
| 27 | Bile duct proliferation (HP:0001408) | 2.88664361 |
| 28 | Abnormal biliary tract physiology (HP:0012439) | 2.88664361 |
| 29 | Abnormality of the renal medulla (HP:0100957) | 2.88656031 |
| 30 | Attenuation of retinal blood vessels (HP:0007843) | 2.83166209 |
| 31 | Abolished electroretinogram (ERG) (HP:0000550) | 2.82763690 |
| 32 | Generalized tonic-clonic seizures (HP:0002069) | 2.82171446 |
| 33 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.81732297 |
| 34 | Abnormality of alanine metabolism (HP:0010916) | 2.81732297 |
| 35 | Hyperalaninemia (HP:0003348) | 2.81732297 |
| 36 | Dialeptic seizures (HP:0011146) | 2.78879027 |
| 37 | Progressive inability to walk (HP:0002505) | 2.78514262 |
| 38 | Mitochondrial inheritance (HP:0001427) | 2.76382377 |
| 39 | Tubular atrophy (HP:0000092) | 2.76043806 |
| 40 | Cystic liver disease (HP:0006706) | 2.74165339 |
| 41 | Aplasia involving bones of the extremities (HP:0009825) | 2.70757917 |
| 42 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.70757917 |
| 43 | Aplasia of the phalanges of the hand (HP:0009802) | 2.70757917 |
| 44 | Pheochromocytoma (HP:0002666) | 2.67578741 |
| 45 | Abnormality of glycolysis (HP:0004366) | 2.67229724 |
| 46 | Increased serum pyruvate (HP:0003542) | 2.67229724 |
| 47 | Absence seizures (HP:0002121) | 2.66637922 |
| 48 | Hyperglycinuria (HP:0003108) | 2.63582907 |
| 49 | Cerebral edema (HP:0002181) | 2.62996314 |
| 50 | Abnormality of the corticospinal tract (HP:0002492) | 2.60644746 |
| 51 | Optic disc pallor (HP:0000543) | 2.55716698 |
| 52 | Broad-based gait (HP:0002136) | 2.55392032 |
| 53 | Large for gestational age (HP:0001520) | 2.54196631 |
| 54 | Neuroendocrine neoplasm (HP:0100634) | 2.51797666 |
| 55 | Hemiparesis (HP:0001269) | 2.51333442 |
| 56 | Renal cortical cysts (HP:0000803) | 2.51032542 |
| 57 | Polydipsia (HP:0001959) | 2.50903187 |
| 58 | Abnormal drinking behavior (HP:0030082) | 2.50903187 |
| 59 | Hyperglycinemia (HP:0002154) | 2.49642224 |
| 60 | Diplopia (HP:0000651) | 2.49500957 |
| 61 | Abnormality of binocular vision (HP:0011514) | 2.49500957 |
| 62 | Leukodystrophy (HP:0002415) | 2.48706616 |
| 63 | Cerebral inclusion bodies (HP:0100314) | 2.44170952 |
| 64 | Hypothermia (HP:0002045) | 2.43361056 |
| 65 | Ketosis (HP:0001946) | 2.41642962 |
| 66 | Parakeratosis (HP:0001036) | 2.39781040 |
| 67 | Pendular nystagmus (HP:0012043) | 2.39614808 |
| 68 | Clumsiness (HP:0002312) | 2.38921649 |
| 69 | Abnormality of glycine metabolism (HP:0010895) | 2.38715335 |
| 70 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.38715335 |
| 71 | Sclerocornea (HP:0000647) | 2.37787299 |
| 72 | Hypoplastic left heart (HP:0004383) | 2.36298899 |
| 73 | Myokymia (HP:0002411) | 2.34901666 |
| 74 | Methylmalonic acidemia (HP:0002912) | 2.33666559 |
| 75 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.31597267 |
| 76 | Increased CSF lactate (HP:0002490) | 2.27841792 |
| 77 | Hepatocellular necrosis (HP:0001404) | 2.25962112 |
| 78 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.23660254 |
| 79 | Generalized aminoaciduria (HP:0002909) | 2.22295658 |
| 80 | Sensory axonal neuropathy (HP:0003390) | 2.20053192 |
| 81 | Dysmetria (HP:0001310) | 2.18415671 |
| 82 | Congenital hepatic fibrosis (HP:0002612) | 2.18330410 |
| 83 | Absent speech (HP:0001344) | 2.16991984 |
| 84 | Hypobetalipoproteinemia (HP:0003563) | 2.15207126 |
| 85 | Lissencephaly (HP:0001339) | 2.14931664 |
| 86 | Polyphagia (HP:0002591) | 2.13232547 |
| 87 | Synostosis involving the elbow (HP:0003938) | 2.12904414 |
| 88 | Humeroradial synostosis (HP:0003041) | 2.12904414 |
| 89 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.12265619 |
| 90 | Congenital primary aphakia (HP:0007707) | 2.12220159 |
| 91 | Delayed CNS myelination (HP:0002188) | 2.11523157 |
| 92 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.10423953 |
| 93 | Gaze-evoked nystagmus (HP:0000640) | 2.10140936 |
| 94 | Anencephaly (HP:0002323) | 2.09741486 |
| 95 | Dysdiadochokinesis (HP:0002075) | 2.09562736 |
| 96 | Decreased central vision (HP:0007663) | 2.09331595 |
| 97 | Thickened helices (HP:0000391) | 2.08966613 |
| 98 | Exercise-induced myalgia (HP:0003738) | 2.08801191 |
| 99 | Confusion (HP:0001289) | 2.08343004 |
| 100 | Increased corneal curvature (HP:0100692) | 2.07925021 |
| 101 | Keratoconus (HP:0000563) | 2.07925021 |
| 102 | Hepatic necrosis (HP:0002605) | 2.07474376 |
| 103 | Cerebral hemorrhage (HP:0001342) | 2.06935087 |
| 104 | Nephrogenic diabetes insipidus (HP:0009806) | 2.05825813 |
| 105 | Blue irides (HP:0000635) | 2.05067918 |
| 106 | Male pseudohermaphroditism (HP:0000037) | 2.03615347 |
| 107 | Furrowed tongue (HP:0000221) | 2.03259183 |
| 108 | Renal Fanconi syndrome (HP:0001994) | 2.03177164 |
| 109 | Glycosuria (HP:0003076) | 2.02433132 |
| 110 | Abnormality of urine glucose concentration (HP:0011016) | 2.02433132 |
| 111 | Abnormality of complement system (HP:0005339) | 2.01929686 |
| 112 | Split foot (HP:0001839) | 2.01436749 |
| 113 | Metabolic alkalosis (HP:0200114) | 2.01416668 |
| 114 | Polyuria (HP:0000103) | 2.00335819 |
| 115 | Drooling (HP:0002307) | 1.98268447 |
| 116 | Excessive salivation (HP:0003781) | 1.98268447 |
| 117 | Generalized myoclonic seizures (HP:0002123) | 1.98260983 |
| 118 | Respiratory failure (HP:0002878) | 1.98007160 |
| 119 | Inability to walk (HP:0002540) | 1.97548572 |
| 120 | Absent/shortened dynein arms (HP:0200106) | 1.97012855 |
| 121 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.97012855 |
| 122 | Supranuclear gaze palsy (HP:0000605) | 1.95415251 |
| 123 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.95415052 |
| 124 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.95415052 |
| 125 | Abnormal eating behavior (HP:0100738) | 1.94207930 |
| 126 | Spontaneous abortion (HP:0005268) | 1.94190583 |
| 127 | X-linked dominant inheritance (HP:0001423) | 1.94081337 |
| 128 | Abnormality of serum amino acid levels (HP:0003112) | 1.93658085 |
| 129 | 3-Methylglutaconic aciduria (HP:0003535) | 1.93373053 |
| 130 | Epidermoid cyst (HP:0200040) | 1.93057914 |
| 131 | Hemiplegia (HP:0002301) | 1.90978122 |
| 132 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.90255941 |
| 133 | Postaxial foot polydactyly (HP:0001830) | 1.88837002 |
| 134 | Pachygyria (HP:0001302) | 1.88271675 |
| 135 | Hypoplasia of the iris (HP:0007676) | 1.88237193 |
| 136 | Abnormal hair whorl (HP:0010721) | 1.88190366 |
| 137 | Ketoacidosis (HP:0001993) | 1.88133594 |
| 138 | Hypoplastic heart (HP:0001961) | 1.87415307 |
| 139 | Cerebellar dysplasia (HP:0007033) | 1.86349780 |
| 140 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.85778855 |
| 141 | Congenital, generalized hypertrichosis (HP:0004540) | 1.85624546 |
| 142 | Scanning speech (HP:0002168) | 1.85070571 |
| 143 | Widely spaced teeth (HP:0000687) | 1.84971599 |
| 144 | Chorioretinal atrophy (HP:0000533) | 1.84950904 |
| 145 | Optic nerve hypoplasia (HP:0000609) | 1.84111020 |
| 146 | Abnormal urine output (HP:0012590) | 1.83978175 |
| 147 | Fair hair (HP:0002286) | 1.82000153 |
| 148 | Severe muscular hypotonia (HP:0006829) | 1.81736668 |
| 149 | Occipital encephalocele (HP:0002085) | 1.80906647 |
| 150 | Intrahepatic cholestasis (HP:0001406) | 1.80842334 |
| 151 | Tachypnea (HP:0002789) | 1.79498010 |
| 152 | Medial flaring of the eyebrow (HP:0010747) | 1.78574457 |
| 153 | Lactic acidosis (HP:0003128) | 1.77393870 |
| 154 | Congenital sensorineural hearing impairment (HP:0008527) | 1.76747478 |
| 155 | Hypophosphatemic rickets (HP:0004912) | 1.75960818 |
| 156 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.75141373 |
| 157 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.74630699 |
| 158 | Spastic gait (HP:0002064) | 1.74298662 |
| 159 | Status epilepticus (HP:0002133) | 1.72725549 |
| 160 | Onion bulb formation (HP:0003383) | 1.72535692 |
| 161 | Slow saccadic eye movements (HP:0000514) | 1.71396848 |
| 162 | Vaginal atresia (HP:0000148) | 1.71087914 |
| 163 | Increased circulating renin level (HP:0000848) | 1.69737262 |
| 164 | Progressive cerebellar ataxia (HP:0002073) | 1.69559990 |
| 165 | Peripheral hypomyelination (HP:0007182) | 1.69266840 |
| 166 | Calf muscle hypertrophy (HP:0008981) | 1.69137160 |
| 167 | Retinal dysplasia (HP:0007973) | 1.68470977 |
| 168 | Genital tract atresia (HP:0001827) | 1.68447952 |
| 169 | Methylmalonic aciduria (HP:0012120) | 1.67560410 |
| 170 | Abnormality of renal resorption (HP:0011038) | 1.66934764 |
| 171 | Gait imbalance (HP:0002141) | 1.66616240 |
| 172 | Truncal ataxia (HP:0002078) | 1.66612170 |
| 173 | Lipid accumulation in hepatocytes (HP:0006561) | 1.65410651 |
| 174 | Hyperlipoproteinemia (HP:0010980) | 1.65205856 |
| 175 | Increased hepatocellular lipid droplets (HP:0006565) | 1.63485126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.93614104 |
| 2 | CASK | 4.42342927 |
| 3 | STK39 | 3.26694319 |
| 4 | MAP4K2 | 2.97382223 |
| 5 | OXSR1 | 2.96997618 |
| 6 | EPHA4 | 2.40647749 |
| 7 | TAOK3 | 2.32839565 |
| 8 | PKN1 | 2.24896379 |
| 9 | ZAK | 2.22808105 |
| 10 | NTRK3 | 2.16871557 |
| 11 | TNIK | 2.10106396 |
| 12 | MUSK | 2.07192023 |
| 13 | NUAK1 | 2.05955363 |
| 14 | PNCK | 2.04533044 |
| 15 | MAP2K7 | 2.03921418 |
| 16 | ACVR1B | 1.98750040 |
| 17 | TLK1 | 1.89241840 |
| 18 | GRK7 | 1.79181911 |
| 19 | ERBB4 | 1.78184498 |
| 20 | TXK | 1.64214394 |
| 21 | BCR | 1.63159659 |
| 22 | CAMK1G | 1.59271513 |
| 23 | PBK | 1.58697063 |
| 24 | MAP3K4 | 1.54976206 |
| 25 | INSRR | 1.53164934 |
| 26 | PHKG2 | 1.51840400 |
| 27 | PHKG1 | 1.51840400 |
| 28 | PRPF4B | 1.47858623 |
| 29 | NTRK2 | 1.44337481 |
| 30 | PRKCE | 1.38573795 |
| 31 | NEK6 | 1.34322439 |
| 32 | WNK4 | 1.34181444 |
| 33 | SGK223 | 1.34124512 |
| 34 | SGK494 | 1.34124512 |
| 35 | MST4 | 1.31708053 |
| 36 | FGR | 1.30847930 |
| 37 | CAMK2B | 1.27816522 |
| 38 | MARK1 | 1.26999233 |
| 39 | CAMKK2 | 1.26399686 |
| 40 | AKT3 | 1.24424254 |
| 41 | CAMK2A | 1.24364155 |
| 42 | CAMK2D | 1.21513282 |
| 43 | FGFR2 | 1.20252183 |
| 44 | FES | 1.15298009 |
| 45 | MAPK15 | 1.09898289 |
| 46 | PIK3CA | 1.08404018 |
| 47 | SIK2 | 1.05800671 |
| 48 | PDK2 | 1.03033838 |
| 49 | ADRBK2 | 1.02379744 |
| 50 | EPHB1 | 1.02005204 |
| 51 | WNK1 | 1.01156163 |
| 52 | BMPR1B | 1.00299528 |
| 53 | MAPK13 | 0.99590515 |
| 54 | NTRK1 | 0.98504921 |
| 55 | EPHA3 | 0.97950106 |
| 56 | TRIM28 | 0.96622384 |
| 57 | PAK6 | 0.94473072 |
| 58 | CDK19 | 0.93739086 |
| 59 | PLK2 | 0.93694369 |
| 60 | CSNK1G1 | 0.92241397 |
| 61 | CAMK2G | 0.92193273 |
| 62 | BMPR2 | 0.90534637 |
| 63 | SGK2 | 0.90184134 |
| 64 | TGFBR1 | 0.89236445 |
| 65 | STK16 | 0.87059812 |
| 66 | CDK5 | 0.86209437 |
| 67 | IRAK2 | 0.86073447 |
| 68 | CAMK1D | 0.86028209 |
| 69 | PAK3 | 0.84413473 |
| 70 | ROCK2 | 0.83463472 |
| 71 | GRK1 | 0.79961373 |
| 72 | IRAK3 | 0.79414154 |
| 73 | OBSCN | 0.75225208 |
| 74 | MAP2K4 | 0.75030452 |
| 75 | UHMK1 | 0.74618550 |
| 76 | PDK3 | 0.74104532 |
| 77 | PDK4 | 0.74104532 |
| 78 | MAPKAPK5 | 0.74075009 |
| 79 | SGK1 | 0.74018720 |
| 80 | NLK | 0.73983493 |
| 81 | PRKCG | 0.73809682 |
| 82 | WNK3 | 0.73740405 |
| 83 | PRKAA2 | 0.73302979 |
| 84 | NME1 | 0.72136872 |
| 85 | PRKCQ | 0.71428784 |
| 86 | TIE1 | 0.71386059 |
| 87 | YES1 | 0.71278627 |
| 88 | MAPK7 | 0.71266893 |
| 89 | MAPK12 | 0.71134040 |
| 90 | CDK3 | 0.69227330 |
| 91 | MAP2K6 | 0.69226108 |
| 92 | PINK1 | 0.69058142 |
| 93 | MYLK | 0.68701693 |
| 94 | BCKDK | 0.68629075 |
| 95 | MKNK2 | 0.68460447 |
| 96 | CAMK1 | 0.67867804 |
| 97 | PRKACA | 0.64741807 |
| 98 | PRKG1 | 0.64096867 |
| 99 | DAPK2 | 0.63866747 |
| 100 | ERBB3 | 0.63654747 |
| 101 | KIT | 0.62873172 |
| 102 | RIPK4 | 0.62381142 |
| 103 | STK38L | 0.61505625 |
| 104 | RPS6KA5 | 0.59330231 |
| 105 | MARK2 | 0.58657119 |
| 106 | TNK2 | 0.58157879 |
| 107 | PDPK1 | 0.57550394 |
| 108 | PIK3CG | 0.56811388 |
| 109 | STK11 | 0.53888275 |
| 110 | CSNK1G2 | 0.53348980 |
| 111 | FER | 0.52919428 |
| 112 | DYRK1A | 0.51868757 |
| 113 | SGK3 | 0.51450570 |
| 114 | PRKCZ | 0.50075058 |
| 115 | GRK5 | 0.50063654 |
| 116 | FYN | 0.47235574 |
| 117 | PRKAA1 | 0.46752915 |
| 118 | MKNK1 | 0.46547164 |
| 119 | CSNK1A1 | 0.45532235 |
| 120 | EIF2AK3 | 0.45427528 |
| 121 | MAP3K12 | 0.45282578 |
| 122 | IGF1R | 0.45206328 |
| 123 | ADRBK1 | 0.45152921 |
| 124 | IRAK1 | 0.45048759 |
| 125 | TEC | 0.43779101 |
| 126 | VRK1 | 0.42093071 |
| 127 | CSNK1A1L | 0.41487112 |
| 128 | MAPKAPK3 | 0.41103441 |
| 129 | PLK4 | 0.40773293 |
| 130 | IKBKB | 0.40443895 |
| 131 | PRKACB | 0.40134526 |
| 132 | PRKACG | 0.39798121 |
| 133 | PTK2B | 0.39768116 |
| 134 | FLT3 | 0.39635089 |
| 135 | PRKCA | 0.39292899 |
| 136 | DYRK2 | 0.39235280 |
| 137 | CSNK1G3 | 0.37862457 |
| 138 | CHUK | 0.36090224 |
| 139 | ITK | 0.34827232 |
| 140 | CSNK1D | 0.33977428 |
| 141 | PRKCI | 0.33465343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.26645586 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.23490323 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.97159571 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.91867659 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.71104058 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.49354311 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.38965031 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.35382054 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.31434220 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.25100538 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.16058216 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 2.12046221 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.01393213 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.95930890 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.92449338 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.92284961 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92149199 |
| 18 | Alzheimers disease_Homo sapiens_hsa05010 | 1.91537192 |
| 19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.82354655 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78866065 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.73386134 |
| 22 | Morphine addiction_Homo sapiens_hsa05032 | 1.69852665 |
| 23 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.66086986 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.61029452 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.60977207 |
| 26 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.59062966 |
| 27 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.56762054 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.54731152 |
| 29 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.50858459 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.47769629 |
| 31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.41422252 |
| 32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.41148347 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41106360 |
| 34 | Taste transduction_Homo sapiens_hsa04742 | 1.40750142 |
| 35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.37251618 |
| 36 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.37246074 |
| 37 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.35633146 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.35393383 |
| 39 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.29807056 |
| 40 | Huntingtons disease_Homo sapiens_hsa05016 | 1.27489940 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.25430520 |
| 42 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.20407859 |
| 43 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.20165887 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.16414344 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16224898 |
| 46 | Circadian entrainment_Homo sapiens_hsa04713 | 1.15498865 |
| 47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13515156 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.13296697 |
| 49 | * Salivary secretion_Homo sapiens_hsa04970 | 1.12260284 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.11833502 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10603163 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.09326082 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.07540785 |
| 54 | Histidine metabolism_Homo sapiens_hsa00340 | 1.05986065 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.05534973 |
| 56 | Phototransduction_Homo sapiens_hsa04744 | 1.04263940 |
| 57 | Long-term depression_Homo sapiens_hsa04730 | 1.03307970 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03186857 |
| 59 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.02163543 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.00758594 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.99754072 |
| 62 | Renin secretion_Homo sapiens_hsa04924 | 0.98281743 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95640251 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.95608158 |
| 65 | Peroxisome_Homo sapiens_hsa04146 | 0.95115859 |
| 66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.94160587 |
| 67 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 0.94147813 |
| 68 | Olfactory transduction_Homo sapiens_hsa04740 | 0.94118326 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90694902 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.89907586 |
| 71 | Axon guidance_Homo sapiens_hsa04360 | 0.89907233 |
| 72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88059240 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87487544 |
| 74 | Protein export_Homo sapiens_hsa03060 | 0.87130500 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84498975 |
| 76 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.79880739 |
| 77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78478715 |
| 78 | Insulin secretion_Homo sapiens_hsa04911 | 0.75835406 |
| 79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.75129156 |
| 80 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.71530533 |
| 81 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70975021 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70541438 |
| 83 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.70387904 |
| 84 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68998366 |
| 85 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67935094 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67235288 |
| 87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.65350450 |
| 88 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.65252965 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63493664 |
| 90 | Cocaine addiction_Homo sapiens_hsa05030 | 0.62178084 |
| 91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61466182 |
| 92 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.58662415 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58607797 |
| 94 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58496141 |
| 95 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57186211 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.56177391 |
| 97 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55964370 |
| 98 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55115213 |
| 99 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54722443 |
| 100 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.54136725 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53873704 |
| 102 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53718762 |
| 103 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.53422481 |
| 104 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52972498 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52642838 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51594780 |
| 107 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51254258 |
| 108 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.50720566 |
| 109 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49344744 |
| 110 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49269674 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48646270 |
| 112 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48614290 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48247322 |
| 114 | Basal transcription factors_Homo sapiens_hsa03022 | 0.47368222 |
| 115 | Asthma_Homo sapiens_hsa05310 | 0.46964153 |
| 116 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46874164 |
| 117 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.46634361 |
| 118 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.44985301 |
| 119 | Bile secretion_Homo sapiens_hsa04976 | 0.43731066 |
| 120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43392552 |
| 121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42708650 |
| 122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42311955 |
| 123 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42125489 |
| 124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41786600 |
| 125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41093261 |
| 126 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.41001129 |
| 127 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40997556 |
| 128 | RNA polymerase_Homo sapiens_hsa03020 | 0.40451621 |
| 129 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40330291 |
| 130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39719746 |
| 131 | Mineral absorption_Homo sapiens_hsa04978 | 0.39709653 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38995859 |
| 133 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37964846 |
| 134 | RNA degradation_Homo sapiens_hsa03018 | 0.31170637 |

